GAMA Healthcare are excited to announce that due to your support we were awarded the Cardiff University Innovation and Impact Awards – People’s Choice Award, as well as winning the Business Innovation award. We would like to thank everyone who voted for us.
The award recognises the impact research has within healthcare and industry in solving issues and shaping society. GAMA Healthcare and Cardiff University’s Knowledge Transfer Partnership focussed on providing clinical proof that Clinell Sporicidal Wipes were effective against Clostridium difficile within a healthcare environment. The KTP collaboration was rated ‘outstanding’ by innovate UK.
Support from the general public and infection prevention and control community means a great deal to us as a company and underlines the importance of research into infection prevention and control. As a company we pride ourselves on promoting good science and innovation to deliver effective products that work in real situations. We are already working on a new KTP with Cardiff University exploring the importance of biofilms, we hope this will be as successful.
GAMA Healthcare are proud to announce that we have won the Business Innovation Prize at Cardiff University’s Innovation and Impact Awards 2015.
The Knowledge Transfer Partnership (KTP) between Cardiff University and GAMA Healthcare has enabled us to sustain our product development portfolio and remain at the forefront of innovation, whilst increasing the University’s international reputation in infection control research.
The KTP grant was awarded by Innovate UK and the Department for Environment, Food & Rural Affairs to support a two year project with Professor Jean-Yves Maillard, Cardiff School of Pharmacy and Pharmaceutical Sciences.
A KTP Associate was recruited and played a key role, transferring Professor Maillard’s knowledge and expertise into GAMA to set up and run clinical trials, whilst training staff across multiple departments. This helped us develop the next generation of products and lay the foundation for in-house research and development capability.
Welcoming the award, Professor Maillard said: “Interaction with industry is crucial to optimise research application ‘in the real world’ and create impactful innovation – here, ensuring the product used as part of an infection control regimen in healthcare settings can make a difference and help infection control against troublesome pathogens.”